FARRAGUT PARTNERS LLP

Lobbying for DEXCOM, INC. · Medical Device Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Medicare/Medicaid

General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.